Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
SYNCOMF | NSE
-1.05
-4.22%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
17/09/2024
23.86
24.91
25.09
23.40
Syncom Formulations (India) Limited manufactures markets and sells pharmaceutical formulation products in India. It offers various products including generics alpha adrenoceptor agonists analgesics antipyretics anti-inflammatory anti-ulcer agents antibiotics antidepressants antifungals antihistamines antimalarial antiplatelet agents antiprotozoal antivirals bronchodilators calcium antagonists cardiac medicines central nervous stimulants cephelo sporins cortico steroids estrogen cough suppressants erectile dysfunction and electrolite. The company also provides histamines homeostatic hypoglycemic hypolipidaemics local anesthetics multivitamins and nutritional supplements sedative anticonvulsants stimulants and sympathomimetic products as well as products used in the treatment of gout. In addition it engages in the trading of commodities and renting of properties. Further the company exports its products. It offers its pharmaceutical formulations products in various dosage forms such as tablets capsules liquids orals liquid vials ampoule injections and dry vial injections dry syrups ointments inhalers and herbals. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore India.
View LessLow Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
High Market Beta (> 0.8)
Rich in Valuation (Price to Book > 8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
104.0%1 month
100.2%3 months
69.5%6 months
58.2%83.97
-
8.59
0.25
0.18
56.02
9.30
-
334.93M
22.81B
272.37M
-
10.49
57.10
45.80
9.30
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
8.40
Range1M
12.50
Range3M
15.59
Rel. volume
0.40
Price X volume
241.91M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Amrutanjan Health Care Limited | AMRUTANJAN | Drug Manufacturers-Specialty & Generic | 779.25 | 22.51B | -0.87% | 53.49 | 0.60% |
Hester Biosciences Limited | HESTERBIO | Drug Manufacturers-Specialty & Generic | 2453.25 | 20.90B | 0.82% | 104.10 | 83.75% |
Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 895.3 | 18.77B | 1.57% | 31.83 | 0.81% |
Lincoln Pharmaceuticals Ltd | LINCOLN | Drug Manufacturers-Specialty & Generic | 773.5 | 15.52B | 2.17% | 15.67 | 0.18% |
Bliss Gvs Pharma Limited | BLISSGVS | Drug Manufacturers-Specialty & Generic | 131.38 | 13.80B | -2.06% | 17.47 | 10.32% |
Bajaj HealthCare Limited | BAJAJHCARE | Drug Manufacturers-Specialty & Generic | 399.15 | 11.15B | 4.16% | n/a | 119.57% |
Nectar Lifesciences Limited | NECLIFE | Drug Manufacturers-Specialty & Generic | 47.86 | 11.03B | -2.09% | 201.62 | 59.44% |
Jagsonpal Pharmaceuticals Limited | JAGSNPHARM | Drug Manufacturers-Specialty & Generic | 410.1 | 10.85B | 0.05% | 53.99 | 4.77% |
Albert David Ltd | ALBERTDAVD | Drug Manufacturers-Specialty & Generic | 1481.35 | 8.45B | -1.90% | 10.74 | 0.87% |
Wanbury Limited | WANBURY | Drug Manufacturers-Specialty & Generic | 256.19 | 8.40B | 1.93% | 16.51 | 416.89% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Signpost India Limited | SIGNPOST | Advertising Agencies | 227.83 | 23.44B | -0.81% | n/a | 80.30% |
Bhagyanagar India Ltd | BHAGYANGR | Copper | 109.13 | 3.49B | 4.60% | 34.15 | 52.08% |
Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 169.14 | 1.88B | 5.00% | 49.20 | 4.88% |
Cubex Tubings Limited | CUBEXTUB | Copper | 98.53 | 1.41B | -0.47% | 34.07 | 21.78% |
Madhav Copper Limited | MCL | Copper | 37.62 | 1.05B | -0.11% | n/a | 32.70% |
Sagardeep Alloys Limited | SAGARDEEP | Copper | 28.04 | 481.85M | -0.85% | 88.75 | 43.14% |
Heads UP Ventures Limited | HEADSUP | Apparel Retail | 15.73 | 355.84M | -5.58% | n/a | 0.00% |
Suumaya Industries Limited | SUULD | Apparel Retail | 5.1 | 306.88M | -0.20% | n/a | -118.72% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 56.02 | - | Expensive |
Ent. to Revenue | 9.30 | - | Cheaper |
PE Ratio | 83.97 | 47.84 | Expensive |
Price to Book | 8.59 | 6.55 | Expensive |
Dividend Yield | - | - | - |
Std. Deviation (3M) | 69.47 | - | Riskier |
Debt to Equity | 0.25 | 0.34 | Cheaper |
Debt to Assets | 0.18 | 0.17 | Par |
Market Cap | 22.81B | - | Emerging |